Florence Anthony A. Jr. - Net Worth and Insider Trading
Florence Anthony A. Jr. Net Worth
The estimated net worth of Florence Anthony A. Jr. is at least $1.3 Billion dollars as of 2024-04-25. Florence Anthony A. Jr. is the Director of Robinhood Markets Inc and owns about 23,822,908 shares of Robinhood Markets Inc (HOOD) stock worth over $407 Million. Florence Anthony A. Jr. is the 10% Owner of Arcellx Inc and owns about 4,745,262 shares of Arcellx Inc (ACLX) stock worth over $243 Million. Florence Anthony A. Jr. is also the 10% Owner of Adaptimmune Therapeutics PLC and owns about 102,478,668 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $109 Million. Besides these, Florence Anthony A. Jr. also holds Savara Inc (SVRA) , Mirum Pharmaceuticals Inc (MIRM) , Korro Bio Inc (KRRO) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Casper Sleep Inc (CSPR) , Ardelyx Inc (ARDX) , Trevi Therapeutics Inc (TRVI) , Mersana Therapeutics Inc (MRSN) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , TRACON Pharmaceuticals Inc (TCON) , Metacrine Inc (MTCR) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Cvent Inc (CVT) , Appian Corp (APPN) . Details can be seen in Florence Anthony A. Jr.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Florence Anthony A. Jr. has not made any transactions after 2024-04-22 and currently still holds the listed stock(s).
Transaction Summary of Florence Anthony A. Jr.
Florence Anthony A. Jr. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Florence Anthony A. Jr. owns 55 companies in total, including Eargo Inc () , Metacrine Inc () , and Mersana Therapeutics Inc () among others .
Click here to see the complete history of Florence Anthony A. Jr.’s form 4 insider trades.
Insider Ownership Summary of Florence Anthony A. Jr.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Eargo Inc | 2020-10-20 | 10 percent owner | |
Metacrine Inc | 2021-12-22 | 10 percent owner | |
Mersana Therapeutics Inc | 2020-04-13 | 10 percent owner | |
Inozyme Pharma Inc | 2020-07-28 | 10 percent owner | |
Genocea Biosciences Inc | 2022-05-25 | 10 percent owner | |
Annexon Inc | 2020-07-23 | 10 percent owner | |
Nkarta Inc | 2020-07-09 | 10 percent owner | |
Akouos Inc | 2020-06-30 | 10 percent owner | |
AVEO Pharmaceuticals Inc | 2020-06-19 | 10 percent owner | |
Surface Oncology Inc | 2018-04-23 | 10 percent owner | |
Trevi Therapeutics Inc | 2022-04-11 | 10 percent owner | |
Imara Inc | 2020-03-11 | 10 percent owner | |
Champions Oncology Inc | 2015-03-11 | 10 percent owner | |
Casper Sleep Inc | 2020-02-10 | director & 10 percent owner | |
Black Diamond Therapeutics Inc | 2020-01-29 | 10 percent owner | |
Adaptimmune Therapeutics PLC | 2020-01-24 | 10 percent owner | |
Regulus Therapeutics Inc | 2020-12-04 | 10 percent owner | |
Ardelyx Inc | 2016-07-18 | 10 percent owner | |
Galera Therapeutics Inc | 2019-11-06 | 10 percent owner | |
Oyster Point Pharma Inc | 2019-10-30 | 10 percent owner | |
Mirum Pharmaceuticals Inc | 2019-07-22 | 10 percent owner | |
Nightstar Therapeutics PLC | 2019-06-07 | 10 percent owner | |
Millendo Therapeutics Inc | 2018-12-07 | 10 percent owner | |
Marker Therapeutics Inc | 2021-03-16 | 10 percent owner | |
MuleSoft Inc | 2018-05-01 | 10 percent owner | |
TRACON Pharmaceuticals Inc | 2018-03-27 | 10 percent owner | |
Cascadian Therapeutics Inc | 2018-03-09 | 10 percent owner | |
ARCA biopharma Inc | 2018-02-26 | 10 percent owner | |
Appian Corp | 2017-11-27 | 10 percent owner | |
Synlogic Inc | 2015-09-30 | 10 percent owner | |
Strongbridge Biopharma PLC | 2018-01-01 | 10 percent owner | |
X4 Pharmaceuticals Inc | 2017-11-20 | 10 percent owner | |
Achaogen Inc | 2016-12-19 | 10 percent owner | |
Interleukin Genetics Inc | 2016-07-29 | 10 percent owner | |
Avalo Therapeutics Inc | 2015-10-14 | 10 percent owner | |
Cvent Inc | 2015-06-11 | director | |
Loxo Oncology Inc | 2014-08-06 | 10 percent owner | |
Care.com Inc | 2014-01-23 | director | |
Savara Inc | 2023-07-17 | 10 percent owner | |
Tempest Therapeutics Inc | 2018-12-07 | 10 percent owner | |
Reneo Pharmaceuticals Inc | 2021-04-08 | 10 percent owner | |
Verona Pharma PLC | 2021-01-01 | 10 percent owner | |
NeueHealth Inc | 2021-06-24 | 10 percent owner | |
Desktop Metal Inc | 2020-12-09 | 10 percent owner | |
Robinhood Markets Inc | 2022-05-03 | director & 10 percent owner | |
Arcellx Inc | 2022-12-21 | 10 percent owner | |
Berkshire Grey Inc | 2021-07-21 | 10 percent owner | |
IonQ Inc | 2021-09-30 | 10 percent owner | |
Monte Rosa Therapeutics Inc | 2021-06-23 | 10 percent owner | |
Senti Biosciences Inc | 2022-06-08 | 10 percent owner | |
ZeroFox Holdings Inc | 2022-08-03 | 10 percent owner | |
Enliven Therapeutics Inc | 2020-03-11 | 10 percent owner | |
Genocea Biosciences Inc | 2018-01-19 | 10 percent owner | |
Revolution Acceleration Acquisition Corp | 2021-07-21 | 10 percent owner | |
Korro Bio Inc | 2023-11-03 | 10 percent owner |
Florence Anthony A. Jr. Latest Holdings Summary
Florence Anthony A. Jr. currently owns a total of 25 stocks. Among these stocks, Florence Anthony A. Jr. owns 23,822,908 shares of Robinhood Markets Inc (HOOD) as of May 3, 2022, with a value of $407 Million and a weighting of 31.39%. Florence Anthony A. Jr. owns 4,745,262 shares of Arcellx Inc (ACLX) as of December 21, 2022, with a value of $243 Million and a weighting of 18.78%. Florence Anthony A. Jr. also owns 102,478,668 shares of Adaptimmune Therapeutics PLC (ADAP) as of January 24, 2020, with a value of $109 Million and a weighting of 8.38%. The other 22 stocks Savara Inc (SVRA) , Mirum Pharmaceuticals Inc (MIRM) , Korro Bio Inc (KRRO) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Casper Sleep Inc (CSPR) , Ardelyx Inc (ARDX) , Trevi Therapeutics Inc (TRVI) , Mersana Therapeutics Inc (MRSN) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , TRACON Pharmaceuticals Inc (TCON) , Metacrine Inc (MTCR) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Cvent Inc (CVT) , Appian Corp (APPN) have a combined weighting of 41.44% among all his current holdings.
Latest Holdings of Florence Anthony A. Jr.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HOOD | Robinhood Markets Inc | 2022-05-03 | 23,822,908 | 17.08 | 406,895,269 |
ACLX | Arcellx Inc | 2022-12-21 | 4,745,262 | 51.31 | 243,455,667 |
ADAP | Adaptimmune Therapeutics PLC | 2020-01-24 | 102,478,668 | 1.06 | 108,627,388 |
SVRA | Savara Inc | 2023-07-17 | 24,471,264 | 4.38 | 107,061,780 |
MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 4,186,243 | 24.00 | 100,469,832 |
KRRO | Korro Bio Inc | 2024-04-22 | 1,090,793 | 59.48 | 64,874,914 |
AVEO | AVEO Pharmaceuticals Inc | 2020-06-19 | 3,952,958 | 15.00 | 59,294,370 |
AKUS | Akouos Inc | 2020-06-30 | 4,294,207 | 13.29 | 57,070,011 |
CSPR | Casper Sleep Inc | 2020-02-10 | 6,222,412 | 6.78 | 42,187,953 |
ARDX | Ardelyx Inc | 2016-07-18 | 5,331,039 | 6.28 | 33,478,925 |
TRVI | Trevi Therapeutics Inc | 2022-04-11 | 11,370,376 | 2.47 | 28,084,829 |
MRSN | Mersana Therapeutics Inc | 2020-04-13 | 7,961,655 | 2.90 | 23,088,800 |
INZY | Inozyme Pharma Inc | 2020-07-28 | 2,437,689 | 4.28 | 10,433,309 |
MRKR | Marker Therapeutics Inc | 2021-03-16 | 1,071,429 | 4.46 | 4,778,573 |
SURF | Surface Oncology Inc | 2018-04-23 | 3,312,877 | 1.07 | 3,544,778 |
RGLS | Regulus Therapeutics Inc | 2020-12-04 | 645,106 | 2.27 | 1,464,391 |
EAR | Eargo Inc | 2020-10-20 | 326,001 | 2.57 | 837,823 |
ILIU | Interleukin Genetics Inc | 2016-07-29 | 55,418,811 | 0.00 | 249,385 |
AKAOQ | Achaogen Inc | 2016-12-19 | 5,215,128 | 0.03 | 130,378 |
TCON | TRACON Pharmaceuticals Inc | 2018-03-27 | 17,330 | 1.87 | 32,407 |
MTCR | Metacrine Inc | 2021-12-22 | 2,563,257 | 0.00 | 3,589 |
ABIO | ARCA biopharma Inc | 2018-02-26 | 0 | 3.48 | 0 |
GNCAQ | Genocea Biosciences Inc | 2022-05-25 | 0 | 0.00 | 0 |
CVT | Cvent Inc | 2015-06-11 | 0 | 6.37 | 0 |
APPN | Appian Corp | 2017-11-27 | 0 | 35.69 | 0 |
Holding Weightings of Florence Anthony A. Jr.
Florence Anthony A. Jr. Form 4 Trading Tracker
According to the SEC Form 4 filings, Florence Anthony A. Jr. has made a total of 2 transactions in Robinhood Markets Inc (HOOD) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Robinhood Markets Inc is the sale of 1,952 shares on May 3, 2022, which brought Florence Anthony A. Jr. around $19,637.
According to the SEC Form 4 filings, Florence Anthony A. Jr. has made a total of 1 transactions in Arcellx Inc (ACLX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Arcellx Inc is the sale of 179 shares on December 21, 2022, which brought Florence Anthony A. Jr. around $5,502.
According to the SEC Form 4 filings, Florence Anthony A. Jr. has made a total of 1 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the acquisition of 7,500,000 shares on January 24, 2020, which cost Florence Anthony A. Jr. around $5 Million.
More details on Florence Anthony A. Jr.'s insider transactions can be found in the Insider Trading History of Florence Anthony A. Jr. table.Insider Trading History of Florence Anthony A. Jr.
- 1
Florence Anthony A. Jr. Trading Performance
GuruFocus tracks the stock performance after each of Florence Anthony A. Jr.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Florence Anthony A. Jr. is 3.93%. GuruFocus also compares Florence Anthony A. Jr.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Florence Anthony A. Jr. within 3 months outperforms 23 times out of 44 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Florence Anthony A. Jr.'s insider trading performs compared to the benchmark.
Performance of Florence Anthony A. Jr.
Average Return
-30.96%
Outperforming Transactions
16%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 5.94 | 3.93 | 2.24 | -30.96 | -41.88 | -34.99 |
Relative Return to S&P 500(%) | 5.33 | 1.09 | -4.92 | -45.35 | -52.5 | -48.7 |
Florence Anthony A. Jr. Ownership Network
Ownership Network List of Florence Anthony A. Jr.
Ownership Network Relation of Florence Anthony A. Jr.
Florence Anthony A. Jr. Owned Company Details
What does Eargo Inc do?
Who are the key executives at Eargo Inc?
Florence Anthony A. Jr. is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .
Eargo Inc () Insider Trades Summary
Over the past 18 months, Florence Anthony A. Jr. made no insider transaction in Eargo Inc (). Other recent insider transactions involving Eargo Inc () include a net sale of 2,012 shares made by William Brownie , a net sale of 725 shares made by Adam Laponis , and a net sale of 92 shares made by Mark Thorpe .
In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,799 shares of Eargo Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,799 shares.
Eargo Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Eargo Inc Insider Transactions
Florence Anthony A. Jr. Mailing Address
Above is the net worth, insider trading, and ownership report for Florence Anthony A. Jr.. You might contact Florence Anthony A. Jr. via mailing address: 5425 Wisconsin Avenue, Suite 800, Chevy Chase Md 20815.